Conclusion The major factors influencing preoperative chemotherapy response were tumor volume,post-chemotherapy AKP,the lowest level of post-chemotherapy peripheral blood leucocytes and chemotherapy protocol.
结论肿瘤体积、化疗后AKP、化疗后白细胞最低值和化疗方案是影响骨肉瘤术前化疗疗效的最主要因素。
参考来源 - 影响ⅡB期骨肉瘤术前化疗疗效的多因素分析Results 1. There were structural changes associating with cell functions in three days after 5’ -DFUR oral administered pre-operation chemotherapy.
结果：1．在电镜下，术前化疗3d可见与细胞功能有关的结构性改变。
参考来源 - 术前口服去氧氟尿苷对胃肠道恶性肿瘤的影响·2,447,543篇论文数据，部分数据来源于NoteExpress
术前化疗并未影响术后死亡率。
Preoperative administration of chemotherapy did not significantly influenced postoperative morbidity.
结论：术前化疗不未增加死亡率或主要的手术并发症。
CONCLUSIONS: Preoperative chemotherapy is not associated with an increase in either the mortality rate or major surgical complications.
目的评价术前化疗在进展期恶性胸腺瘤治疗中的作用。
Objective To assess the effect of preoperative chemotherapy on invasive thymoma.
应用推荐